SCOPUS 정보 검색 플랫폼

Volumn 13, Issue 5, 2011, Pages 799-807

Gemcitabine-loaded chitosan microspheres. Characterization and biological in vitro evaluation

(8) Ventura, Cinzia Anna a Cannavà, Carmela a Stancanelli, Rosanna a Paolino, Donatella b Cosco, Donato b La Mantia, Antonio c Pignatello, Rosario d Tommasini, Silvana a

a UNIVERSITY OF MESSINA (Italy)

b UNIVERSITY MAGNA GRAECIA OF CATANZARO (Italy)

c STMICROELECTRONICS (Italy)

d UNIVERSITY OF CATANIA (Italy)

Author keywords

A549 cells; Chitosan microspheres; Cytotoxic activity; Dextran sulphate; Gemcitabine

Indexed keywords

A549 CELLS; ANTICANCER DRUG; CHITOSAN MICROSPHERES; CYTOTOXIC ACTIVITIES; DELIVERY SYSTEMS; DEXTRANE; DRUG RELEASE; ENCAPSULATED DRUGS; ENCAPSULATION EFFICIENCY; GEMCITABINE; HUMAN LUNG CANCER CELLS; IMMEDIATE DRUG RELEASE; IN-VITRO; IN-VITRO EVALUATION; MORPHOLOGICAL CHARACTERIZATION; POLYANIONS; SPHERICAL PARTICLE; SULFATE COMPLEXES; SULPHATES; TECHNOLOGICAL PARAMETERS;

CHITOSAN; CYTOTOXICITY; DEXTRAN; ENCAPSULATION; MICROSPHERES; PARTICLE SIZE ANALYSIS;

DRUG PRODUCTS;

CHITOSAN MICROSPHERE; DEXTRAN SULFATE; GEMCITABINE; MICROSPHERE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; ENCAPSULATION EFFICIENCY; ENTRAPMENT EFFICIENCY; HUMAN; HUMAN CELL; IN VITRO STUDY; LOADING CAPACITY; PARTICLE SIZE; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY;

ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TUMOR; CHITOSAN; DEOXYCYTIDINE; DEXTRAN SULFATE; DRUG CARRIERS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LUNG NEOPLASMS; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; PARTICLE SIZE;

EID: 80053924188 PISSN: 13872176 EISSN: 15728781 Source Type: Journal
DOI: 10.1007/s10544-011-9550-6 Document Type: Article

Times cited : (28)

References (27)

1
- 1042288101
- Gemcitabine-induced severe pulmonary toxicity
- DOI 10.1046/j.0767-3981.2003.00206.x
- F Barlési P Villani C Doddoli C Gimenez JP Kleisbauer 2004 Fundam. Clin. Pharmacol. 18 85 10.1046/j.0767-3981.2003.00206.x (Pubitemid 38200923)
- (2004) Fundamental and Clinical Pharmacology , vol.18 , Issue.1 , pp. 85-91
- Barlesi, F.¹ Villani, P.² Doddoli, C.³ Gimenez, C.⁴ Kleisbauer, J.-P.⁵

2
- 18844438857
- Gemcitabine monotherapy in recurrent ovarian cancer: From the bench to the clinic
- DOI 10.1111/j.1525-1438.2005.15352.x
- MA Bookman 2005 Int. J. Gynecol. Cancer. 15 12 10.1111/j.1525-1438.2005. 15352.x (Pubitemid 40696472)
- (2005) International Journal of Gynecological Cancer , vol.15 , Issue.SUPPL. 1 , pp. 12-17
- Bookman, M.A.¹

3
- 69049106405
- 10.1007/s00280-009-0957-1
- D Cosco A Bulotta M Ventura C Celia T Calimeri G Perri D Paolino N Costa P Neri P Tassone P Tagliaferri M Fresta 2009 Cancer Chemother. Pharmacol. 64 1009 10.1007/s00280-009-0957-1
- (2009) Cancer Chemother. Pharmacol. , vol.64 , pp. 1009
- Cosco, D.¹ Bulotta, A.² Ventura, M.³ Celia, C.⁴ Calimeri, T.⁵ Perri, G.⁶ Paolino, D.⁷ Costa, N.⁸ Neri, P.⁹ Tassone, P.¹⁰ Tagliaferri, P.¹¹ Fresta, M.¹²

4
- 48549107174
- 10.1002/jps.21043
- G Di Colo Y Zambito C Zaino 2008 J. Pharm. Sci. 97 1652 10.1002/jps.21043
- (2008) J. Pharm. Sci. , vol.97 , pp. 1652
- Di Colo, G.¹ Zambito, Y.² Zaino, C.³

5
- 33846699695
- Retrospective review in patients with pulmonary metastases of renal cell carcinoma receiving inhaled recombinant interleukin-2
- DOI 10.1097/CAD.0b013e328011a4fc, PII 0000181320070300000008
- E Esteban-González J Carballido V Navas Z Torregrosa A Muñoz MA de Mon 2007 Anticancer Drugs 18 291 10.1097/CAD.0b013e328011a4fc (Pubitemid 46192982)
- (2007) Anti-Cancer Drugs , vol.18 , Issue.3 , pp. 291-296
- Esteban-Gonzalez, E.¹ Carballido, J.² Navas, V.³ Torregrosa, Z.⁴ Munoz, A.⁵ Alvarez De Mon, M.⁶

6
- 21344435041
- Safety of pulmonary administration of gemcitabine in rats
- DOI 10.1089/jam.2005.18.198
- F Gagnadoux A Le Pape T Urban J Montharu L Vecellio JC Dubus V Leblond P Diot D Grimbert JL Racineux E Lemarié 2005 J. Aerosol. Med. 18 198 10.1089/jam.2005.18.198 (Pubitemid 40911360)
- (2005) Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung , vol.18 , Issue.2 , pp. 198-206
- Gagnadoux, F.¹ Le Pape, A.² Urban, T.³ Montharu, J.⁴ Vecellio, L.⁵ Dubus, J.-C.⁶ Leblond, V.⁷ Diot, P.⁸ Grimbert, D.⁹ Racineux, J.-L.¹⁰ Lemarie, E.¹¹

7
- 33646486081
- 10.1007/s00280-005-0146-9
- F Gagnadoux V Leblond L Vecellio J Hureaux A Le Pape M Boisdron-Celle J Montharu C Majoral J Fournier T Urban P Diot J Racineux L Lemarié 2006 Cancer Chemother. Pharmacol. 58 237 10.1007/s00280-005-0146-9
- (2006) Cancer Chemother. Pharmacol. , vol.58 , pp. 237
- Gagnadoux, F.¹ Leblond, V.² Vecellio, L.³ Hureaux, J.⁴ Le Pape, A.⁵ Boisdron-Celle, M.⁶ Montharu, J.⁷ Majoral, C.⁸ Fournier, J.⁹ Urban, T.¹⁰ Diot, P.¹¹ Racineux, J.¹² Lemarié, L.¹³

8
- 45949111406
- 10.1089/jamp.2007.0656
- F Gagnadoux J Hureaux L Vecellio T Urban A Le Pape I Valo J Montharu V Leblond M Boisdron-Celle S Lerondel C Majoral P Diot JL Racineux E Lemarie 2008 J. Aerosol. Med. Pulm. Drug Deliv. 21 61 10.1089/jamp.2007.0656
- (2008) J. Aerosol. Med. Pulm. Drug Deliv. , vol.21 , pp. 61
- Gagnadoux, F.¹ Hureaux, J.² Vecellio, L.³ Urban, T.⁴ Le Pape, A.⁵ Valo, I.⁶ Montharu, J.⁷ Leblond, V.⁸ Boisdron-Celle, M.⁹ Lerondel, S.¹⁰ Majoral, C.¹¹ Diot, P.¹² Racineux, J.L.¹³ Lemarie, E.¹⁴

9
- 0036198121
- T Ganz 2002 J. Clin. Invest. 109 693
- (2002) J. Clin. Invest. , vol.109 , pp. 693
- Ganz, T.¹

10
- 30444441465
- The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis
- DOI 10.1164/rccm.200504-613PP
- S Gelperina K Kisich MD Iseman L Heifets 2005 Am. J. Respir. Crit. Care Med. 172 1487 10.1164/rccm.200504-613PP (Pubitemid 43076534)
- (2005) American Journal of Respiratory and Critical Care Medicine , vol.172 , Issue.12 , pp. 1487-1490
- Gelperina, S.¹ Kisich, K.² Iseman, M.D.³ Heifets, L.⁴

11
- 0032588712
- JR Hammond S Lee PJ Ferguson 1999 J Pharm. Exper. Ther. 288 1185
- (1999) J Pharm. Exper. Ther. , vol.288 , pp. 1185
- Hammond, J.R.¹ Lee, S.² Ferguson, P.J.³

12
- 77954229475
- 10.3390/md8061750
- R Harris E Lecumberri A Heras 2010 Mar. Drugs 8 1750 10.3390/md8061750
- (2010) Mar. Drugs , vol.8 , pp. 1750
- Harris, R.¹ Lecumberri, E.² Heras, A.³

13
- 0037268904
- Role of gemcitabine in the treatment of advanced and metastatic breast cancer
- DOI 10.1159/000069315
- V Heinemann 2003 Oncology 64 191 10.1159/000069315 (Pubitemid 36438803)
- (2003) Oncology , vol.64 , Issue.3 , pp. 191-206
- Heinemann, V.¹

14
- 0023783698
- V Heinemann LW Hertel GB Grindey W Plunkett 1988 Cancer Res. 48 4024
- (1988) Cancer Res. , vol.48 , pp. 4024
- Heinemann, V.¹ Hertel, L.W.² Grindey, G.B.³ Plunkett, W.⁴

15
- 0028832342
- V Heinemann L Schulz RD Issels W Plunkett 1995 Semin. Oncol. 22 11
- (1995) Semin. Oncol. , vol.22 , pp. 11
- Heinemann, V.¹ Schulz, L.² Issels, R.D.³ Plunkett, W.⁴

16
- 0028124642
- Chitosan as a novel nasal delivery system for peptide drugs
- DOI 10.1023/A:1018901302450
- L Illum NF Farraj SS Davis 1994 Pharm. Res. 11 1186 10.1023/A: 1018901302450 (Pubitemid 24259861)
- (1994) Pharmaceutical Research , vol.11 , Issue.8 , pp. 1186-1189
- Illum, L.¹ Farraj, N.F.² Davis, S.S.³

17
- 22244439824
- Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases
- DOI 10.1002/ijc.21011
- NV Koshkina ES Kleinerman 2005 Int. J. Cancer. 116 458 10.1002/ijc.21011 (Pubitemid 40993344)
- (2005) International Journal of Cancer , vol.116 , Issue.3 , pp. 458-463
- Koshkina, N.V.¹ Kleinerman, E.S.²

18
- 2342533018
- High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer: Results of a dose-finding study
- DOI 10.1016/j.lungcan.2003.12.004, PII S0169500203006329
- C Kouroussis D Mavroudis S Kakolyris A Voloudaki K Kalbakis J Souglakos S Agelaki K Malas V Bozionelou V Georgoulias 2004 Lung Cancer. 44 363 10.1016/j.lungcan.2003.12.004 (Pubitemid 38609445)
- (2004) Lung Cancer , vol.44 , Issue.3 , pp. 363-368
- Kouroussis, C.¹ Mavroudis, D.² Kakolyris, S.³ Voloudaki, A.⁴ Kalbakis, K.⁵ Souglakos, J.⁶ Agelaki, S.⁷ Malas, K.⁸ Bozionelou, V.⁹ Georgoulias, V.¹⁰

19
- 23444461899
- PH-sensitive polyelectrolyte complex gel microspheres composed of chitosan/sodium tripolyphosphate/dextran sulfate: Swelling kinetics and drug delivery properties
- DOI 10.1016/j.colsurfb.2005.06.010, PII S0927776505001840
- C Lin D Yu MC Yang 2005 Colloids Surf. B: Biointerfaces 44 143 10.1016/j.colsurfb.2005.06.010 (Pubitemid 41111541)
- (2005) Colloids and Surfaces B: Biointerfaces , vol.44 , Issue.2-3 , pp. 143-151
- Lin, W.-C.¹ Yu, D.-G.² Yang, M.-C.³

20
- 0029958486
- 10.1046/j.1365-2125.1996.00493.x
- BJL Lipworth 1996 Br. J. Clin. Pharmacol. 42 697 10.1046/j.1365-2125. 1996.00493.x
- (1996) Br. J. Clin. Pharmacol. , vol.42 , pp. 697
- Lipworth, B.J.L.¹

21
- 12844287650
- Combined modality therapy of gemcitabine and radiation
- DOI 10.1634/theoncologist.10-1-34
- B Pauwels AE Korst F Lardon JB Vermorken 2005 Oncologist. 10 34 10.1634/theoncologist.10-1-34 (Pubitemid 40171250)
- (2005) Oncologist , vol.10 , Issue.1 , pp. 34-51
- Pauwels, B.¹ Korst, A.E.C.² Lardon, F.³ Vermorken, J.B.⁴

22
- 0036365649
- 10.1089/089426802760292609
- MS Shaik A Haynes J McSween O Ikediobi N Kanikkannan M Singh 2002 J. Aerosol. Med. 15 261 10.1089/089426802760292609
- (2002) J. Aerosol. Med. , vol.15 , pp. 261
- Shaik, M.S.¹ Haynes, A.² McSween, J.³ Ikediobi, O.⁴ Kanikkannan, N.⁵ Singh, M.⁶

23
- 0035868782
- S Sharma D White AR Imondi ME Placke DM Vail MG Kris 2001 J. Clin. Oncol. 19 1839
- (2001) J. Clin. Oncol. , vol.19 , pp. 1839
- Sharma, S.¹ White, D.² Imondi, A.R.³ Placke, M.E.⁴ Vail, D.M.⁵ Kris, M.G.⁶

24
- 0038670289
- In vitro degradation rates of partially N-acetylated chitosans in human serum
- DOI 10.1016/S0008-6215(96)00332-1, PII S0008621596003321
- KM Varum MM Myhr RJ Hjerde O Smidsrød 1997 Carbohydr. Res. 299 99 10.1016/S0008-6215(96)00332-1 (Pubitemid 27138460)
- (1997) Carbohydrate Research , vol.299 , Issue.1-2 , pp. 99-101
- Varum, K.M.¹ Myhr, M.M.² Hjerde, R.J.N.³ Smidsrod, O.⁴

25
- 0037436923
- Bioadhesive microspheres as a controlled drug delivery system
- DOI 10.1016/S0378-5173(03)00087-5
- JK Vasir K Tambwekar S Garg 2003 Int. J. Pharm. 255 13 10.1016/S0378-5173(03)00087-5 (Pubitemid 36369587)
- (2003) International Journal of Pharmaceutics , vol.255 , Issue.1-2 , pp. 13-32
- Vasir, J.K.¹ Tambwekar, K.² Garg, S.³

26
- 37849015123
- 10.1016/j.ejpb.2007.05.011
- CA Ventura S Tommasini E Crupi I Giannone V Cardile T Musumeci G Puglisi 2008 Eur. J. Pharm. Biopharm. 68 235 10.1016/j.ejpb.2007.05.011
- (2008) Eur. J. Pharm. Biopharm. , vol.68 , pp. 235
- Ventura, C.A.¹ Tommasini, S.² Crupi, E.³ Giannone, I.⁴ Cardile, V.⁵ Musumeci, T.⁶ Puglisi, G.⁷

27
- 42649125889
- 10.1016/j.ijpharm.2008.02.011
- W Yang JI Peters RO Williams III 2008 Int. J. Pharm. 356 239 10.1016/j.ijpharm.2008.02.011
- (2008) Int. J. Pharm. , vol.356 , pp. 239
- Yang, W.¹ Peters, J.I.² Williams Iii, R.O.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.